Clinical Trends for August 2016

Ryan Syrek


August 26, 2016

Clinical Trend of the Week (August 13-19): Psoriasis

Some bad news and some good news helped drive our top search this week. A recent study determined that psoriasis is associated with a significantly higher risk of chronic pancreatitis (CP). The incidence of CP was almost double in individuals with psoriasis than among those in the control group. The good news comes in the form of a new clinical trial that could change treatment for adults who have moderate-to-severe plaque psoriasis. A phase 2/3 clinical trial found that Piclidenoson is safe and possibly more effective than apremilast (Otezla), which is already approved for plaque psoriasis treatment. This is particularly welcome news because nearly 70% of biological treatments are discontinued by patients with moderate-to-severe psoriasis due to side effects or loss of efficacy. A busy news week helped push this term into the top spot.

For more information on psoriasis, read here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.